Sequential therapy for Helicobacter pylori eradication: a critical review.
about
Treatment of Helicobacter pylori infection: Current and future insightsInfectious Aetiology of Marginal Zone Lymphoma and Role of Anti-Infective TherapyHelicobacter pylori: Effect of coexisting diseases and update on treatment regimensRole of Helicobacter pylori infection in gastric carcinogenesis: Current knowledge and future directionsTherapy of Helicobacter pylori: present medley and future prospectiveHelicobacter pylori update: gastric cancer, reliable therapy, and possible benefits.Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapySteering Evolution with Sequential Therapy to Prevent the Emergence of Bacterial Antibiotic ResistanceDoes emerging Clarithromycin resistance signal an obituary to empirical standard triple therapy for Helicobacter pylori infection?Optimal treatment strategy for Helicobacter pylori: era of antibiotic resistance.Green Synthesis of Silver Nanoparticles: Structural Features and In Vivo and In Vitro Therapeutic Effects against Helicobacter pylori Induced GastritisModified sequential Helicobacter pylori therapy: proton pump inhibitor and amoxicillin for 14 days with clarithromycin and metronidazole added as a quadruple (hybrid) therapy for the final 7 days.Treatment of Helicobacter pylori infection: Past, present and futureConcomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies.Empiric therapies for Helicobacter pylori infections.Probiotics in Helicobacter pylori eradication therapy: a systematic review and meta-analysisA randomized study comparing levofloxacin, omeprazole, nitazoxanide, and doxycycline versus triple therapy for the eradication of Helicobacter pyloriIsolation and diagnosis of Helicobacter pylori by a new method: microcapillary culture.Structural Basis for the Inhibition of Helicobacter pylori α-Carbonic Anhydrase by Sulfonamides.Frequency of antibiotic resistance in Helicobacter pylori strains isolated from the northern population of Iran.Comparison of quadruple and triple Furazolidone containing regimens on eradication of helicobacter pylori.The challenge of Helicobacter pylori resistance to antibiotics: the comeback of bismuth-based quadruple therapy.Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori.Comparison of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori eradication in inactive peptic ulcer disease and the efficiency of sequential therapy in inactive peptic ulcer disease and non-ulcer dyspepsiaHybrid therapy for Helicobacter pylori infection: A systemic review and meta-analysis.Hybrid vs sequential therapy for eradication of Helicobacter pylori in Taiwan: A prospective randomized trial.7-Day Nonbismuth-Containing Concomitant Therapy Achieves a High Eradication Rate for Helicobacter pylori in Taiwan.Moxifloxacin-containing triple therapy after non-bismuth quadruple therapy failure for Helicobacter pylori infectionA 14-day course of triple therapy is superior to a 10-day course for the eradication of Helicobacter pylori: A Canadian study conducted in a 'real world' setting.Helicobacter Pylori "Test-and-Treat" Strategy for Management of Dyspepsia: A Comprehensive ReviewNonbismuth concomitant quadruple therapy for Helicobacter pylori eradication in Chinese regions: A meta-analysis of randomized controlled trials.Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidenceA randomized controlled trial comparing sequential with triple therapy for Helicobacter pylori in an Aboriginal community in the Canadian NorthCurrent recommendations for Helicobacter pylori therapies in a world of evolving resistance.Prolonged treatment duration is required for successful Helicobacter pylori eradication with proton pump inhibitor triple therapy in Canada.Efficacy of 1st-line bismuth-containing quadruple therapies with levofloxacin or clarithromycin for the eradication of Helicobacter pylori infection: A 1-week, open-label, randomized trial.Detection of genotypic clarithromycin-resistant Helicobacter pylori by string tests.Recent Insights into Antibiotic Resistance in Helicobacter pylori Eradication.Eradication of Helicobacter pylori infection: which regimen first?Helicobacter pylori: future perspectives in therapy reflecting three decades of experience.
P2860
Q26769707-45133AC1-CAEE-4F3D-A21C-DC74F7DE3A05Q26770344-A81C77FC-9823-4283-A9F6-8B6B93A5C900Q26777635-2E93A454-02D1-4878-A623-47902CB11731Q26778023-8CC8CA52-29B2-46A0-A617-9C6B086CDE92Q26823120-7DDAAB27-3949-42EF-8726-3DC0F0E9D024Q27333657-0D45A8AE-7D94-4A2C-BDC5-FA13C40C876FQ28296156-8A380000-DEB3-4016-A142-ED3E8E99F9B2Q28547894-C70EDA84-27CA-48C7-A056-0C6A1179A46FQ30381104-DA92868C-2619-4689-B84D-8355F6D7B8ABQ33626779-055AED05-0975-4602-8965-07E4C442DAB2Q34151373-C7A1A190-731F-4950-AF27-1A8C99D41197Q34314718-FBFAC88D-4C01-43C6-BF85-02D3E04A7363Q34508830-7E4A212C-36CF-47CE-AF30-5D138823344FQ34827671-D1E96990-B6C2-4F1D-93DB-6053D9B57815Q35045027-FB919A15-49DD-4962-A96F-88788A4E5288Q35375748-124BFB6D-1B32-45FE-99D5-903EF9A35CFCQ35532235-A6A800C4-C9BB-4093-87E9-9B25FA565CC3Q35574964-39C96F69-73CD-4E54-9CB7-F1E92EF6CF16Q35641361-9EB6336A-B983-40DD-B2E5-8742C9410925Q35744435-BE75AC9C-0ABD-4BC9-8C1F-EAED402064BCQ35765342-D10B2B64-239B-48A4-A34A-E53F7DD72B00Q35810200-9022C7F7-C7DA-4A2D-9F84-BA7D7F2DB4DBQ35841617-8A8A3BE3-B09B-4062-A4A1-57EC47131FFAQ35860594-7F97D669-4700-4AD0-9235-EA6D792FD80DQ35868940-760E99C6-FC58-4448-A7BD-2472D356F439Q36085602-BF6E718B-3FBD-478F-B582-F80219FC3486Q36129001-33C27A9B-EADE-4857-8D0C-236A6F821E26Q36360839-01EA2669-3B36-4B2F-B65D-CA6A695D2A61Q36425705-7915281D-B50C-40A1-94DC-8DFF2B2A8C6CQ36740047-1A18D28D-C691-42AA-8B14-46AF7FD1F9EFQ37012409-4DD15B13-BBB7-4E06-96EC-CF392EAAB3BCQ37315773-E8878A5F-7E50-40A8-A90A-11C0AE22CE39Q37558559-568B3C6D-F09E-4806-A010-2D618D99D3E4Q37591509-A89834EA-A2DB-49F1-BCCF-E85E21C46076Q37640593-F101E78B-C9F0-4647-8214-C716D5D21C3BQ37656247-E0CDD4F3-3E33-4F00-B8D1-71DCFDF19AABQ37660716-AD78C11C-09C2-44D9-AC27-777BD019EA93Q38029324-381A64AC-73B7-4323-94FE-867E12D413F9Q38191565-D7B6F8D5-D7DC-4A54-8041-B3BEA3C68A59Q38191566-3FA2804B-3F65-47BC-8CA1-23D0BEBB1DB2
P2860
Sequential therapy for Helicobacter pylori eradication: a critical review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Sequential therapy for Helicobacter pylori eradication: a critical review.
@en
Sequential therapy for Helicobacter pylori eradication: a critical review.
@nl
type
label
Sequential therapy for Helicobacter pylori eradication: a critical review.
@en
Sequential therapy for Helicobacter pylori eradication: a critical review.
@nl
prefLabel
Sequential therapy for Helicobacter pylori eradication: a critical review.
@en
Sequential therapy for Helicobacter pylori eradication: a critical review.
@nl
P2093
P1476
Sequential therapy for Helicobacter pylori eradication: a critical review.
@en
P2093
Anthony O'Connor
Colm A O'Morain
Javier P Gisbert
Xavier Calvet
P304
P356
10.1097/MCG.0B013E3181C8A1A3
P577
2010-05-01T00:00:00Z